As predicted, CREB1 enhanced cell viability (Fig. 4c), shortened the cell doubling time (Fig. 4d), accelerated genome DNA replication (Fig. 4e, f), and promoted the transition of cells from the G1 phase to the S phase (Fig. 4g) in HCC cell lines. This evidence concerns the gene CREB1 and hepatocellular carcinoma.